Costs of antibiotic resistance - Separating trait effects and selective effects

Evolutionary Applications

Volumn 8, Issue 3, 2015, Pages 261-272

  Hall, Alex R ^a,b   Angst, Daniel C ^a,b   Schiessl, Konstanze T ^a,b   Ackermann, Martin ^a,b  

^a ETH ZURICH   (Switzerland)

^b SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

Author keywords

Antibiotic resistance; Cost of resistance; Epistasis; Experimental evolution; Genotype by environment interaction

Indexed keywords

EID: 84925306196     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12187     Document Type: Article

References (129)

1. Alekshun, M. N., and S. B. Levy 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128:1037-1050.
2. Andersson, D. I. 2003. Persistence of antibiotic resistant bacteria. Current Opinion in Microbiology 6:452-456.
3. Andersson, D. I., and D. Hughes 2010. Antibiotic resistance and its cost: is it possible to reverse resistance? Nature Reviews Microbiology 8:260-271.
4. Andersson, D. I., and D. Hughes 2011. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiology Reviews 35:901-911.
5. Andersson, D. I., and B. R. Levin 1999. The biological cost of antibiotic resistance. Current Opinion in Microbiology 2:489-493.
6. Applebee, M. K., M. J. Herrgård, and B. O. Palsson 2008. Impact of individual mutations on increased fitness in adaptively evolved strains of Escherichia coli. Journal of Bacteriology 190:5087-5094.
7. Arason, V. A., A. Gunnlaugsson, J. A. Sigurdsson, H. Erlendsdottir, S. Gudmundsson, and K. G. Kristinsson 2002. Clonal spread of resistant Pneumococci despite diminished antimicrobial use. Microbial Drug Resistance 8:187-192.
8. Bachmann, H., M. Fischlechner, I. Rabbers, N. Barfa, F. Branco dos Santos, D. Molenaar, and B. Teusink 2013. Availability of public goods shapes the evolution of competing metabolic strategies. Proceedings of the National Academy of Sciences of the United States of America 110:14302-14307.
9. Baker-Austin, C., M. S. Wright, R. Stepanauskas, and J. V. McArthur 2006. Co-selection of antibiotic and metal resistance. Trends in Microbiology 14:176-182.
10. Baquero, F., and M. C. Negri 1997. Selective compartments for resistant microorganisms in antibiotic gradients. BioEssays 19:731-736.
11. Bataillon, T., T. Zhang, and R. Kassen 2011. Cost of adaptation and fitness effects of beneficial mutations in Pseudomonas fluorescens. Genetics 189:939-949.
12. Bean, D. C., D. M. Livermore, I. Papa, and L. M. Hall 2005. Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. Journal of Antimicrobial Chemotherapy 56:962-964.
13. Bergstrom, C. T., and M. Feldgarden 2008. The ecology and evolution of antibiotic-resistant bacteria. In S. C. Stearns, and J. C. Koella, eds. Evolution in Health and Disease, pp. 125-137. Oxford University Press, Oxford.
14. Bershtein, S., M. Segal, R. Bekerman, N. Tokuriki, and D. S. Tawfik 2006. Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. Nature 444:929-932.
15. Björkman, J., D. Hughes, and D. I. Andersson 1998. Virulence of antibiotic-resistant Salmonella typhimurium. Proceedings of the National Academy of Sciences of the United States of America 95:3949-3953.
16. Björkman, J., I. Nagaev, O. G. Berg, D. Hughes, and D. I. Andersson 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287:1479-1482.
17. Borrell, S., Y. Teo, F. Giardina, E. M. Streicher, M. Klopper, J. Feldmann, B. Müller et al. 2013. Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis. Evolution, Medicine, and Public Health 1:65-74.
18. Brandis, G., M. Wrande, L. Liljas, and D. Hughes 2012. Fitness-compensatory mutations in rifampicin-resistant RNA polymerase. Molecular Microbiology 85:142-151.
19. Brinas, L., M. A. Moren, T. Teshager, M. Zarazaga, Y. Saenz, C. Porrero, L. Dominguez et al. 2003. β-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain. Microbial Drug Resistance 9:201-209.
20. Brockhurst, M. A., N. Colegrave, and D. E. Rozen 2011. Next-generation sequencing as a tool to study microbial evolution. Molecular Ecology 20:972-980.
21. Caswell, H. 1989. Matrix Population Models. Sinauer Associates, Sunderland, MA.
22. Chambers, H. F., and F. R. Deleo 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology 7:629-641.
23. Charlesworth, B. 1994. Evolution in Age-Structured Populations, 2nd edn. Cambridge University Press, Cambridge.
24. Chevin, L. M. 2011. On measuring selection in experimental evolution. Biology Letters 7:210-213.
25. Cohen, T., B. Sommers, and M. Murray 2003. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. The Lancet 3:13-21.
26. Comas, I., S. Borrell, A. Roetzer, G. Rose, B. Malla, M. Kato-Maeda, J. Galagan et al. 2012. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nature Genetics 44:106-112.
27. Conrad, T. M., M. Frazier, A. R. Joyce, B. K. Cho, E. M. Knight, N. E. Lewis, R. Landick et al. 2010. RNA polymerase mutants found through adaptive evolution reprogram Escherichia coli for optimal growth in minimal media. Proceedings of the National Academy of Sciences of the United States of America 107:20500-20505.
28. Costerton, J. W., Z. Lewandowski, D. E. Caldwell, D. R. Korber, and H. M. Lappin-Scott 1995. Microbial biofilms. Annual Review of Microbiology 49:711-745.
29. Da Silva, P. E. A., and J. C. Palomino 2011. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. Journal of Antimicrobial Chemotherapy 66:1417-1430.
30. D'Costa, V. M., K. M. McGrann, D. W. Hughes, and G. D. Wright 2006. Sampling the antibiotic resistome. Science 311:374-377.
31. Dekel, E., and U. Alon 2005. Optimality and evolutionary tuning of the expression level of a protein. Nature 436:588-592.
32. Depardieu, F., I. Podglajen, R. Leclercq, E. Collatz, and P. Courvalin 2007. Modes and modulations of antibiotic resistance gene expression. Clinical Microbiology Reviews 20:79-114.
33. DePristo, M. A., D. M. Weinreich, and D. L. Hartl 2005. Missense meanderings in sequence space: a biophysical view of protein evolution. Nature Reviews Genetics 6:678-687.
34. Derewacz, D. K., C. R. Goodwin, C. R. McNees, J. A. McLean, and B. O. Bachmann 2013. Antimicrobial drug resistance affects broad changes in metabolomic phenotype in addition to secondary metabolism. Proceedings of the National Academy of Sciences of the United States of America 110:2336-2341.
35. Dutta, D., K. Shatalin, V. Epshtein, M. E. Gottesman, and E. Nudler 2011. Linking RNA polymerase backtracking to genome instability in E. coli. Cell 146:533-543.
36. Dykhuizen, D. E., and A. M. Dean 1990. Enzyme activity and fitness - evolution in solution. Trends in Ecology & Evolution 5:257-262.
37. Enne, V. I., D. M. Livermore, P. Stephens, and L. M. Hall 2001. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357:1325-1328.
38. Fell, D., and A. Cornish-Bowden 1997. Understanding the Control of Metabolism, Vol. 2. Portland Press, London.
39. Fitzsimmons, J. M., S. E. Schoustra, J. T. Kerr, and R. Kassen 2010. Population consequences of mutational events: effects of antibiotic resistance on the r/K trade-off. Evolutionary Ecology 24:227-236.
40. Foucault, M. L., F. Depardieu, P. Courvalin, and C. Grillot-Courvalin 2010. Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proceedings of the National Academy of Sciences of the United States of America 107:16964-16969.
41. Frank, S. A. 2010. The trade-off between rate and yield in the design of microbial metabolism. Journal of Evolutionary Biology 23:609-613.
42. Frank, S. A. 2014. Microbial metabolism: optimal control of uptake versus synthesis. PeerJ 2:e267.
43. Garibyan, L., T. Huang, M. Kim, E. Wolff, A. Nguyen, T. Nguyen, A. Diep et al. 2003. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair 2:593-608.
44. Gottesman, B. S., Y. Carmeli, P. Shitrit, and M. Chowers 2009. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clinical Infectious Diseases 49:869-875.
45. Gourion, B., M. Rossignol, and J. A. Vorholt 2006. A proteomic study of Methylobacterium extorquens reveals a response regulator essential for epiphytic growth. Proceedings of the National Academy of Sciences of the United States of America 103:13186-13191.
46. Gullberg, E., S. Cao, O. G. Berg, C. Ilbäck, L. Sandegren, D. Hughes, and D. I. Andersson 2011. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathogens 7:e1002158.
47. Guo, B. N., K. Abdelraouf, K. R. Ledesma, M. Nikolaou, and V. H. Tam 2012. Predicting bacterial fitness cost associated with drug resistance. Journal of Antimicrobial Chemotherapy 67:928-932.
48. Hall, A. R. 2013. Genotype-by-environment interactions due to adaptation and antibiotic resistance in Escherichia coli. Journal of Evolutionary Biology 26:1655-1664.
49. Hall, A. R., and R. C. MacLean 2011. Epistasis buffers the fitness effects of rifampicin-resistance mutations in Pseudomonas aeruginosa. Evolution 65:2370-2379.
50. Hall, A. R., V. F. Griffiths, R. C. MacLean, and N. Colegrave 2010. Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa. Proceedings of the Royal Society B: Biological Sciences 277:643-650.
51. Hall, A. R., J. C. Iles, and R. C. MacLean 2011. The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase. Genetics 187:44-53.
52. Hanski, I. 1999. Metapopulation Ecology. Oxford University Press, Oxford.
53. Hermsen, R., J. B. Deris, and T. Hwa 2012. On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proceedings of the National Academy of Sciences of the United States of America 109:10775-10780.
54. Imamovic, L., and M. O. Sommer 2013. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Science Translational Medicine 5:204ra132.
55. Jin, D. J., and C. A. Gross 1989. Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli. Journal of Bacteriology 171:5229-5231.
56. Johnson, C. N., D. E. Briles, W. H. Jr Benjamin, S. K. Hollingshead, and K. B. Waites 2005. Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae. Emerging Infectious Diseases 11:814-820.
57. Joyner, D. C., and S. E. Lindow 2000. Heterogeneity of iron bioavailability on plants assessed with a whole-cell GFP-based bacterial biosensor. Microbiology 146:2435-2445.
58. Kim, S. H., and C. I. Wei 2007. Antibiotic resistance and Caco-2 cell invasion of Pseudomonas aeruginosa isolates from farm environments and retail products. International Journal of Food Microbiology 115:356-363.
59. Kreft, J. U. 2004. Biofilms promote altruism. Microbiology 150:2751-2760.
60. Kurland, C. G. 1992. Translational accuracy and the fitness of bacteria. Annual Review of Genetics 26:29-50.
61. Lázár, V., G. Pal Singh, R. Spohn, I. Nagy, B. Horváth, M. Hrtyan, R. Busa-Fekete et al. 2013. Bacterial evolution of antibiotic hypersensitivity. Molecular Systems Biology 9:700.
62. Lehner, B. 2011. Molecular mechanisms of epistasis within and between genes. Trends in Genetics 27:323-331.
63. Lendenmann, U., M. Snozzi, and T. Egli 1996. Kinetics of the simultaneous utilization of sugar mixtures by Escherichia coli in continuous culture. Applied and Environmental Microbiology 62:1493-1499.
64. Lenski, R. E., M. R. Rose, S. C. Simpson, and S. C. Tadler 1991. Long-term experimental evolution in Escherichia coli 1. Adaptation and divergence during 2, 000 generations. American Naturalist 138:1315-1341.
65. Levin, S. A. 1976. Population dynamic models in heterogeneous environments. Annual Review of Ecology and Systematics 7:287-310.
66. Levin, B. R. 2001. Minimizing potential resistance: a population dynamics view. Clinical Infectious Diseases 33:S161-S169.
67. Levin, B. R., V. Perrot, and N. Walker 2000. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154:985-997.
68. Levy, S. B., and B. Marshall 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nature Medicine 10:S122-S129.
69. Lindgren, P. K., A. Karlsson, and D. Hughes 2003. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrobial Agents and Chemotherapy 47:3222-3232.
70. Lindgren, P. K., L. L. Marcusson, D. Sandvang, N. Frimodt-Møller, and D. Hughes 2005. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrobial Agents and Chemotherapy 49:2343-2351.
71. Livermore, D. M. 1995. β-lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8:557-584.
72. Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clinical Infectious Diseases 34:634-640.
73. MacLean, R. C., and A. Buckling 2009. The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa. PLoS Genetics 5:e1000406.
74. MacLean, R. C., and I. Gudelj 2006. Resource competition and social conflict in experimental populations of yeast. Nature 441:498-501.
75. Maisnier-Patin, S., and D. I. Andersson 2004. Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Research in Microbiology 155:360-369.
76. Maisnier-Patin, S., O. G. Berg, L. Liljas, and D. I. Andersson 2002. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Molecular Microbiology 46:355-366.
77. Maisnier-Patin, S., W. Paulander, A. Pennhag, and D. I. Andersson 2007. Compensatory evolution reveals functional interactions between ribosomal proteins S12 L14 and L19. Journal of Molecular Biology 366:207-215.
78. Mann, E. L., and S. W. Chisholm 2000. Iron limits the cell division rate of Prochlorococcus in the eastern equatorial Pacific. Limnology and Oceanography 45:1067-1076.
79. Marcusson, L. L., N. Frimodt-Møller, and D. Hughes 2009. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. Plos Pathogens 5:e1000541.
80. Mariam, D. H., Y. Mengistu, S. E. Hoffner, and D. I. Andersson 2004. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 48:1289-1294.
81. Martínez, J. L., and F. Rojo 2011. Metabolic regulation of antibiotic resistance. Fems Microbiology Reviews 35:768-789.
82. Miller, M. B., and B. L. Bassler 2001. Quorum sensing in bacteria. Annual Review of Microbiology 55:165-199.
83. Minami, S., A. Yotsuji, M. Inoue, and S. Mitsuhashi 1980. Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 18:382-385.
84. Miskinyte, M., and I. Gordo 2013. Increased survival of antibiotic-resistant Escherichia coli inside macrophages. Antimicrobial Agents and Chemotherapy 57:189-195.
85. Mortlock, R. P., ed. 1984. Microorganisms as Model Systems for Studying Evolution. Plenum, New York.
86. Nagaev, I., J. Björkman, D. I. Andersson, and D. Hughes 2001. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Molecular Microbiology 40:433-439.
87. Nguyen, T. N. M., Q. G. Phan, L. P. Duong, K. P. Bertrand, and R. E. Lenski 1989. Effects of carriage and expression of the Tn10 tetracycline-resistance operon on the fitness of Escherichia coli K12. Molecular Biology and Evolution 6:213-225.
88. Nilsson, A. I., E. Kugelberg, O. G. Berg, and D. I. Andersson 2004. Experimental adaptation of Salmonella typhimurium to mice. Genetics 168:1119-1130.
89. Nikaido, H. 1998. Multiple antibiotic resistance and efflux. Current Opinion in Microbiology 1:516-523.
90. Nikaido, H., and J. M. Pagès 2012. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiology Reviews 36:340-363.
91. Nilsson, A. I., A. Zorzet, A. Kanth, S. Dahlström, O. G. Berg, and D. I. Andersson 2006. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proceedings of the National Academy of Sciences of the United States of America 103:6976-6981.
92. Pakula, A. A., and R. T. Sauer 1989. Genetic analysis of protein stability and function. Annual Review of Genetics 23:289-310.
93. Palmer, A. C., and R. Kishony 2013. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nature Reviews Genetics 14:243-248.
94. Paulander, W., S. Maisnier-Patin, and D. I. Andersson 2009. The fitness cost of streptomycin resistance depends on rpsL mutation, carbon source and rpoS (σ(s)). Genetics 183:539-546.
95. Perkins, A. E., and W. L. Nicholson 2008. Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants. Journal of Bacteriology 190:807-814.
96. Perron, G. G., A. R. Hall, and A. Buckling 2010. Hypermutability and compensatory adaptation in antibiotic-resistant bacteria. American Naturalist 176:303-311.
97. Petersen, A., F. M. Aarestrup, and J. E. Olsen 2009. The in vitro fitness cost of antimicrobial resistance in Escherichia coli varies with the growth conditions. FEMS Microbiology Letters 299:53-59.
98. Pfeiffer, T., S. Schuster, and S. Bonhoeffer 2001. Cooperation and competition in the evolution of ATP-producing pathways. Science 292:504-507.
99. Piddock, L. J. 2006. Multidrug-resistance efflux pumps - not just for resistance. Nature Reviews Microbiology 4:629-636.
100. Proshkin, S., A. R. Rahmouni, A. Mironov, and E. Nudler 2010. Cooperation between translating ribosomes and RNA polymerase in transcription elongation. Science 328:504-508.
101. Reynolds, M. G. 2000. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 156:1471-1481.
102. Rodríguez-Verdugo, A., B. S. Gaut, and O. Tenaillon 2013. Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress. BMC Evolutionary Biology 13:50.
103. Rozen, D. E., L. McGee, B. R. Levin, and K. P. Klugman 2007. Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 51:412-416.
104. Ruusala, T., D. Andersson, M. Ehrenberg, and C. G. Kurland 1984. Hyper-accurate ribosomes inhibit growth. The EMBO Journal 3:2575.
105. Salverda, M. L., E. Dellus, F. A. Gorter, A. J. Debets, J. van der Oost, R. F. Hoekstra, D. S. Tawfik et al. 2011. Initial mutations direct alternative pathways of protein evolution. PLoS Genetics 7:e1001321.
106. San Millan, A., K. Heilbron, and R. C. MacLean 2014. Positive epistasis between co-infecting plasmids promotes plasmid survival in bacterial populations. The ISME Journal 8:601-612.
107. Schechner, V., E. Temkin, S. Harbarth, Y. Carmeli, and M. J. Schwaber 2013. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clinical Microbiology Reviews 26:289-307.
108. Schenk, M. F., I. G. Szendro, M. L. Salverda, J. Krug, and J. A. G. M. de Visser 2014. Patterns of epistasis between beneficial mutations in an antibiotic resistance gene. Molecular Biology and Evolution 30:1779-1787.
109. Schrag, S. J., V. Perrot, and B. R. Levin 1997. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proceedings of the Royal Society of London. Series B: Biological Sciences 264:1287-1291.
110. Seppälä, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager, and P. Huovinen 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. New England Journal of Medicine 337:441-446.
111. Sezonov, G., D. Joseleau-Petit, and R. D'Ari 2007. Escherichia coli physiology in Luria-Bertani broth. Journal of Bacteriology 189:8746-8749.
112. Shcherbakov, D., R. Akbergenov, T. Matt, P. Sander, D. I. Andersson, and E. C. Böttger 2010. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Molecular Microbiology 77:830-840.
113. Silva, R. F., S. C. Mendonça, L. M. Carvalho, A. M. Reis, I. Gordo, S. Trindade, and F. Dionisio 2011. Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations. PLoS Genetics 7:e1002181.
114. Smith, R., and J. Coast 2013. The true cost of antimicrobial resistance. British Medical Journal 346:f1493.
115. Snitkin, E. S., A. M. Zelazny, P. J. Thomas, F. Stock, NISC Comparative Sequencing Program, D. K., Henderson, and T. N., Palmore et al. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Science Translational Medicine 4:148ra116.
116. Stoebel, D. M., A. M. Dean, and D. E. Dykhuizen 2008. The cost of expression of Escherichia coli lac operon proteins is in the process, not in the products. Genetics 178:1653-1660.
117. Sundqvist, M., P. Geli, D. I. Andersson, M. Sjölund-Karlsson, A. Runehagen, H. Cars, K. Abelson-Storby et al. 2010. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. Journal of Antimicrobial Chemotherapy 65:350-360.
118. Tenaillon, O., A. Rodríguez-Verdugo, R. L. Gaut, P. McDonald, A. F. Bennett, A. D. Long, and B. S. Gaut 2012. The molecular diversity of adaptive convergence. Science 335:457-461.
119. Tokuriki, N., F. Stricher, J. Schymkowitz, L. Serrano, and D. S. Tawfik 2007. The stability effects of protein mutations appear to be universally distributed. Journal of Molecular Biology 369:1318-1332.
120. Trindade, S., A. Sousa, K. B. Xavier, F. Dionisio, M. G. Ferreira, and I. Gordo 2009. Positive epistasis drives the acquisition of multidrug resistance. PLoS Genetics 5:e1000578.
121. Trindade, S., A. Sousa, and I. Gordo 2012. Antibiotic resistance and stress in the light of Fisher's model. Evolution 66:3815-3824.
122. Trinh, V., M. F. Langelier, J. Archambault, and B. Coulombe 2006. Structural perspective on mutations affecting the function of multisubunit RNA polymerases. Microbiology and Molecular Biology Reviews 70:12-36.
123. de Visser, J. A., T. F. Cooper, and S. F. Elena 2011. The causes of epistasis. Proceedings of the Royal Society B: Biological Sciences 278:3617-3624.
124. de Vos, M., B. Müller, S. Borrell, P. A. Black, P. D. van Helden, R. M. Warren, S. Gagneux et al. 2013. Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrobial Agents and Chemotherapy 57:827-832.
125. Walsh, C. 2000. Molecular mechanisms that confer antibacterial drug resistance. Nature 406:775-781.
126. Ward, H., G. G. Perron, and R. C. Maclean 2009. The cost of multiple drug resistance in Pseudomonas aeruginosa. Journal of Evolutionary Biology 22:997-1003.
127. Weinreich, D. M., N. F. Delaney, M. A. DePristo, and D. L. Hartl 2006. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312:111-114.
128. Whiteley, M., K. M. Lee, and E. P. Greenberg 1999. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences of the United States of America 96:13904-13909.
129. Wrande, M., J. R. Roth, and D. Hughes 2008. Accumulation of mutants in "aging" bacterial colonies is due to growth under selection, not stress-induced mutagenesis. Proceedings of the National Academy of Sciences of the United States of America 105:11863-11868.